Predictors of Heart Failure in Patients With Stable Coronary Artery Disease: A PEACE Study
暂无分享,去创建一个
Marc A Pfeffer | Jean Rouleau | S. Solomon | M. Pfeffer | B. Gersh | M. Rice | K. Jablonski | J. Rouleau | E. Braunwald | J. Hsia | A. Maggioni | T. Huynh | M. Zabalgoitia | F. Clemenza | Scott D Solomon | Bernard J Gersh | Eugene Braunwald | Judith Hsia | Aldo P Maggioni | Kathleen A Jablonski | T. Cuddy | E. Lewis | Eldrin F Lewis | Miguel Zabalgoitia | Thao Huynh | Madeline Murguia Rice | Francesco Clemenza | Thomas E Cuddy
[1] E. Vittinghoff,et al. Predictors of Heart Failure Among Women With Coronary Disease , 2004, Circulation.
[2] K. Swedberg,et al. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial). , 1997, The American journal of cardiology.
[3] M. Pencina,et al. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.
[4] S. Solomon,et al. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. , 2008, European heart journal.
[5] K. Fox,et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.
[6] L. Fried,et al. Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults , 2005, Annals of Internal Medicine.
[7] David W. Hosmer,et al. Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .
[8] J. Murabito,et al. Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. , 1992, JAMA.
[9] Jeroen J. Bax,et al. Incidence and predictors of heart failure during long-term follow-up after stress Tc-99m sestamibi tomography in patients with suspected coronary artery disease , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[10] 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina , 2007 .
[11] S. Yusuf,et al. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials , 2006, The Lancet.
[12] W. Kannel,et al. Prognosis after initial myocardial infarction: the Framingham study. , 1979, The American journal of cardiology.
[13] A. Hasslocher-Moreno,et al. Development and validation of a risk score for predicting death in Chagas' heart disease. , 2006, The New England journal of medicine.
[14] Salim Yusuf,et al. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study , 2003, Circulation.
[15] S. Solomon,et al. Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial , 2006, Circulation.
[16] P. Kowey,et al. Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. , 2005, The American journal of cardiology.
[17] K. Thygesen,et al. Prognosis after first myocardial infarction. , 2009, Acta medica Scandinavica.
[18] M. Pfeffer,et al. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. , 2007, Journal of the American College of Cardiology.
[19] G. Lamas,et al. Characterization of health‐related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM , 2007, European journal of heart failure.
[20] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[21] S. Yusuf,et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.
[22] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[23] M. Domanski,et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.
[24] S. Yusuf,et al. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function? , 2006, European heart journal.
[25] John V. Wylie,et al. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18. , 2004, American heart journal.
[26] B. Davis,et al. Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension , 1997 .
[27] G. Lamas,et al. The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST). , 2006, American heart journal.
[28] B. Davis,et al. Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial , 2006, Circulation.
[29] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[30] S. Hohnloser,et al. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. , 1999, Journal of the American College of Cardiology.
[31] E. Aliot,et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.
[32] Hans L. Hillege,et al. Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.
[33] H. Heinzl,et al. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. , 1997, Computer methods and programs in biomedicine.
[34] K. Pyörälä. Interpopulation correlations between serum cholesterol level and the occurrence of coronary heart disease. , 1987, European heart journal.
[35] R. Kronmal,et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. , 2008, Journal of the American College of Cardiology.
[36] W. Kannel. Epidemiology and prevention of cardiac failure: Framingham Study insights. , 1987, European heart journal.
[37] Tom Greene,et al. Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.
[38] M. Pfeffer,et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. , 2003, Journal of the American College of Cardiology.
[39] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[40] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[41] M. Pfeffer,et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.
[42] M. Blaufox,et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. , 1997, JAMA.
[43] G. Assmann,et al. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.